These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 27050801

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, National Heart, Lung and Blood Institute's Asthma Clinical Research Network.
    Lancet; 2009 Nov 21; 374(9703):1754-64. PubMed ID: 19932356
    [Abstract] [Full Text] [Related]

  • 3. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
    Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):676-87. PubMed ID: 19910613
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.
    J Allergy Clin Immunol; 2006 Oct 01; 118(4):809-16. PubMed ID: 17030231
    [Abstract] [Full Text] [Related]

  • 6. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.
    Lancet; 2007 Dec 22; 370(9605):2118-25. PubMed ID: 18156033
    [Abstract] [Full Text] [Related]

  • 7. beta-Adrenergic receptor polymorphisms and response to salmeterol.
    Wechsler ME, Lehman E, Lazarus SC, Lemanske RF, Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, DiMango E, Kraft M, Leone F, Martin RJ, Peters SP, Szefler SJ, Liu W, Israel E, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.
    Am J Respir Crit Care Med; 2006 Mar 01; 173(5):519-26. PubMed ID: 16322642
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 01; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.
    J Allergy Clin Immunol; 2011 Aug 01; 128(2):315-22. PubMed ID: 21807250
    [Abstract] [Full Text] [Related]

  • 12. Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.
    Yancey SW, Klotsman M, Ortega HG, Edwards LD, Anderson WH.
    Curr Med Res Opin; 2009 Apr 01; 25(4):1011-8. PubMed ID: 19275519
    [Abstract] [Full Text] [Related]

  • 13. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.
    Allergy; 2005 Mar 01; 60(3):309-16. PubMed ID: 15679715
    [Abstract] [Full Text] [Related]

  • 14. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline.
    Rebordosa C, Kogevinas M, Guerra S, Castro-Giner F, Jarvis D, Cazzoletti L, Pin I, Siroux V, Wjst M, Antò JM, de Marco R, Estivill X, Corsico AG, Nielsen R, Janson C.
    Eur Respir J; 2011 Nov 01; 38(5):1029-35. PubMed ID: 21436355
    [Abstract] [Full Text] [Related]

  • 15. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.
    Kim SH, Ye YM, Hur GY, Lee HY, Jee YK, Lee SH, Holloway JW, Park HS.
    Yonsei Med J; 2009 Apr 30; 50(2):182-8. PubMed ID: 19430548
    [Abstract] [Full Text] [Related]

  • 16. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study.
    Wang Y, Chen P, Dai A, Shang S, Kong L.
    Clin Ther; 2016 Dec 30; 38(12):2622-2627.e1. PubMed ID: 27913032
    [Abstract] [Full Text] [Related]

  • 17. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov 30; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 18. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
    Pediatr Pulmonol; 2009 Nov 30; 44(11):1132-42. PubMed ID: 19824054
    [Abstract] [Full Text] [Related]

  • 19. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
    Carroll CL, Stoltz P, Schramm CM, Zucker AR.
    Chest; 2009 May 30; 135(5):1186-1192. PubMed ID: 19029431
    [Abstract] [Full Text] [Related]

  • 20. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.
    Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI.
    Thorax; 2000 Sep 30; 55(9):762-7. PubMed ID: 10950895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.